Myriad Genetics, Inc. (MYGN)
3.97
-0.25
(-5.92%)
USD |
NASDAQ |
May 29, 16:00
4.00
+0.03
(+0.76%)
After-Hours: 05:09
Myriad Genetics Total Assets (Quarterly) : 673.70M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Natera, Inc. | 2.614B |
| BioRestorative Therapies, Inc. | 4.640M |
| CareDx, Inc. | 411.06M |
| Exagen, Inc. | 51.96M |
| Sera Prognostics, Inc. | 93.54M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 336.30M |
| Shareholders Equity (Quarterly) | 337.40M |
| Debt to Equity Ratio | 0.6269 |
| Current Ratio | 2.402 |
| Net Debt Paydown Yield | -3.35% |